The Director, Drug Metabolism, Pharmacokinetics & Modeling (DMPK&M) at Takeda will provide strategic leadership within the Gastrointestinal and Inflammation (GI2) Therapeutic Area Unit. The role focuses on integrating various scientific disciplines to support drug development from early discovery through clinical progress, emphasizing decision-making driven by quantitative modeling.